Skip to content

THERMAGE FLX TT16.00F6-500Recalls & reported problems

Solta Medical · FLX TREATMENT TIP, BODY, 16.0CM2, 1200 REP · Class 1

All models of THERMAGE FLX (8)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
6
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00816995021360), received between May 10, 2024 and Sep 5, 2025 — classified as 6 injuries.

The most frequently reported specific device problem is “Excessive Heating” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 1 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 2 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem5
  • Excessive Heating1

Patient problems

  • Erythema5
  • Partial thickness (Second Degree) Burn4
  • Blister3
  • Burn(s)3
  • Skin Inflammation/ Irritation2
  • Full thickness (Third Degree) Burn1
  • Hyperpigmentation1
  • Hypopigmentation1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjurySep 5, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A USER FACILITY REPORTED THAT A PATIENT EXPERIENCED A BURN TO THEIR SUPRAUMBILICAL AREA DURING A THERMAGE FLX BODY TREATMENT. THE PATIENT HAD RECEIVED THERMAGE FLX TREATMENT TO THEIR ABDOMEN AND LEGS. AFTER THE INJURY OCCURRED, THE PATIENT WAS TREATED WITH LA ROCHE-POSAY BRANDED CICAPLAST BALM. THE PATIENT¿S CURRENT STATUS IS THEY ARE HEALING HOWEVER HYPOPIGMENTED SPOTS ARE EXPECTED. THE PATIENT TAKES MAGNESIUM AND HYDROLYZED COLLAGEN, AS WELL AS APPLYING MOISTURIZING CREAM, ON A DAILY BASIS. THE PATIENT HAS NOT RECEIVED ANY OTHER TREATMENT TO THE SAME SYMPTOM AREA ON THE PROCEDURE DATE OR WITHIN 90 DAYS PRIOR. THE PATIENT HAS NEVER RECEIVED TREATMENT TO THE SAME SYMPTOM AREA IN THEIR PAST HISTORY. A SOLTA MEDICAL REVIEWER EXAMINED TWO IMAGES OF THE PATIENT¿S ABDOMEN. ONE IMAGE SHOWED A BLISTER AROUND THE UMBILICUS, WHILE THE OTHER DEPICTED A SMALL BLISTER WITH SURROUNDING ERYTHEMA. NO DATES WERE PROVIDED FOR THE IMAGES. SOLTA MEDICAL BRANDED CRYOGEN AND 4 BOTTLES OF CRYOGEN WERE USED WITH THE HIGHEST LEVEL OF TREATMENT AT 1.5. THE INJURY REPORTEDLY OCCURRED DURING THE ¿FIRST PASS¿ IN THE ABDOMEN AREA. IT IS NOT KNOWN IF THE PROVIDER USED A STAMPING OR SLIDING METHOD. NO SYSTEM ERR

    Patient problems: Blister; Burn(s); Erythema; Hypopigmentation

    MAUDE report 22979940 ↗
  • InjuryAug 6, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A USER FACILITY REPORTED TO A DISTRIBUTOR THAT A PATIENT SUSTAINED A 1.5 X 1.5 CM SECOND DEGREE BURN TO THE RIGHT MEDIAL UPPER ARM TWO DAYS POST BILATERAL ARMS THERMAGE FLX TREATMENT. AVAILABLE IMAGES OF THE PATIENT¿S INNER UPPER ARM WERE REVIEWED BY THE MEDICAL REVIEWER. SEVERAL UNDATED PHOTOGRAPHS DEPICT A WOUND APPROXIMATELY 1 X 1 INCH IN SIZE, LOCATED ON THE INNER ASPECT OF THE UPPER ARM. THE IMAGES CAPTURE THE WOUND AT VARIOUS STAGES OF THE HEALING PROCESS. EARLY IMAGES SHOW AN OPEN WOUND WITH RAW TISSUE EXPOSURE, WHILE SUBSEQUENT IMAGES DEMONSTRATE PROGRESSIVE IMPROVEMENT WITH FORMATION OF GRANULATION TISSUE AND PARTIAL RE-EPITHELIALIZATION. IN THE LATEST AVAILABLE IMAGES, THE WOUND APPEARS FULLY CLOSED, THOUGH RESIDUAL ERYTHEMA AND MILD LOCALIZED INFLAMMATION ARE STILL PRESENT, INDICATING ONGOING TISSUE REMODELING. THE PATIENT RECEIVED WOUND CARE WITH SILVADENE® (SILVER SULFADIAZINE), AND DRESSING CHANGES EVERY TWO DAYS. THE CURRENT STATUS WAS REPORTED AS STABLE; HOWEVER, THE FINAL OUTCOME REMAINS UNKNOWN. THE PATIENT IS NOT TAKING ANY REGULAR (PRESCRIPTION OR NON-PRESCRIPTION) MEDICATIONS, VITAMINS, OR HERBAL SUPPLEMENTS, NOR IS THE PATIENT USING ANY TOPICAL PRODUCT (BOTH M

    Patient problems: Burn(s); Erythema; Partial thickness (Second Degree) Burn; Skin Inflammation/ Irritation

    MAUDE report 22731651 ↗
  • InjuryAug 6, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A USER FACILITY REPORTED TO A DISTRIBUTOR THAT A PATIENT EXPERIENCED SEVERE BURNS ON THE RIGHT INNER THIGH, ALONG WITH BURNS ON THE LEFT KNEECAP, ELBOW AND CHIN AREA TWO HOURS POST THERMAGE FLX PROCEDURE. AVAILABLE PICTURES WERE REVIEWED BY THE MEDICAL REVIEWER. THREE PHOTOS TAKEN 7 DAYS POST TREATMENT REVEALED CRUSTED WOUNDS LOCATED ON THE INNER THIGH OF ONE LEG AND THE LATERAL ASPECT OF THE KNEE ON THE OPPOSITE LEG. FOLLOW-UP IMAGING 1 MONTH AND 4 DAYS POST TREATMENT INCLUDED FOUR PHOTOGRAPHS. THESE DEMONSTRATED THAT THE WOUND ON THE LATERAL KNEE HAD HEALED, WITH RESIDUAL POST-INFLAMMATORY HYPERPIGMENTATION. IN CONTRAST, THE WOUNDS ON THE INNER THIGH OF THE CONTRALATERAL LEG HAD NOT FULLY HEALED. WHILE THE CRUSTS WERE NO LONGER PRESENT, THE UNDERLYING SKIN APPEARED ERYTHEMATOUS AND IN THE PROCESS OF RE-EPITHELIALIZATION, INDICATING INCOMPLETE HEALING. INFORMATION PROVIDED DESCRIBES APPROXIMATELY 4¿5 LESIONS, MEASURING 2 X 2 CM AND 1 X 1 CM IN SIZE, DESCRIBED AS SECOND AND THIRD-DEGREE BURNS WITH AREAS OF NECROSIS, LOCATED ON THE RIGHT INNER THIGH. THE PATIENT RECEIVED WOUND CARE, DRESSINGS EVERY 2-3 DAYS WITH 2 SESSIONS OF DEBRIDEMENT, AND A TOPICAL BURN CREAM (PRODUCT NOT SPECIF

    Patient problems: Erythema; Full thickness (Third Degree) Burn; Hyperpigmentation; Necrosis; Partial thickness (Second Degree) Burn

    MAUDE report 22731647 ↗
  • InjuryMar 21, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A USER FACILITY REPORTED THAT A PATIENT EXPERIENCED MULTIPLE 2ND DEGREE BURNS ON THEIR ABDOMEN FOLLOWING A THERMAGE FLX BODY TREATMENT. THE REPORT WAS RECEIVED APPROXIMATELY 65 DAYS POST-PROCEDURE, IT IS UNKNOWN WHEN SYMPTOMS WERE FIRST OBSERVED. THE PATIENT WAS GIVEN AN UNKNOWN OINTMENT FOR THEIR INJURIES AND HEAT OR ICE WAS APPLIED POST PROCEDURE. THE PATIENT DID NOT TREAT THEIR BURN WITH ANY OVER THE COUNTER SOLUTIONS AT HOME. THEIR CURRENT STATUS IS THEY ARE UNDERGOING LASER TREATMENT AND GRADUALLY RECOVERING. PERMANENT DAMAGE OR SCARRING IS EXPECTED. NO OTHER TREATMENTS WERE PERFORMED IN THE SAME SYMPTOM AREA ON THE PROCEDURE DATE OR WITHIN 90 DAYS PRIOR. THE PATIENT DOES NOT HAVE A HISTORY OF RECEIVING AESTHETIC TREATMENTS IN THE SYMPTOM AREA. INFORMATION FOR THE CRYOGEN AND COUPLING FLUID USED IN THE TREATMENT WERE NOT PROVIDED. IT IS UNKNOWN IF A STAMPING OR SLIDING METHOD WAS USED. THE PATIENT WAS NOT ADMINISTERED ANY PAIN MEDICATION OR ANESTHESIA PRIOR TO THE TREATMENT. THEY WERE ALERT AND ABLE TO PROVIDE FEEDBACK DURING THE PROCEDURE. THE HIGHEST LEVEL OF TREATMENT WAS 5.5. NO SYSTEM ERRORS OCCURRED DURING THE TREATMENT. IT IS UNKNOWN IF THIS WAS THE FIRST TIME THE BODY

    Patient problems: Partial thickness (Second Degree) Burn

    MAUDE report 21663802 ↗
  • InjuryOct 26, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A USER FACILITY REPORTED THAT A PATIENT EXPERIENCED BURNS AROUND THE BELLY BUTTON AFTER A THERMAGE FLX TREATMENT TO THE ABDOMEN, AND THAT THE BURNS SCARRED. THE FACILITY REPORTED THAT THE ENERGY LEVELS WERE MAINTAINED BETWEEN 0.5 ¿ 1.0 THROUGHOUT THE PROCEDURE. NO OTHER TREATMENTS WERE BEING PERFORMED AT THE SAME TIME IN THE SYMPTOM AREA, AND TO THE BEST OF THE PROVIDER¿S KNOWLEDGE NONE HAD BEEN PERFORMED WITHIN THE PRIOR NINETY DAYS. SOLTA CRYOGEN AND SIX TUBES OF SOLTA COUPLING FLUID WERE USED DURING THE TREATMENT. THE TREATMENT TIP WAS INSPECTED PRIOR TO THIS INITIAL USE, WITH NOTHING ATYPICAL NOTED. THE TREATMENT TIP WAS INSPECTED THROUGHOUT THE TREATMENT AND NO ANOMALIES WERE NOTED. THE PATIENT VISITED A DOCTOR APPROXIMATELY 13 DAYS AFTER THE TREATMENT AND WAS DIAGNOSED WITH A HYPERTROPHIC SCAR. SPOTTED SCARS WERE OBSERVED ON THE ABDOMINAL WALL. THE PATIENT SHOWED A PICTURE FROM THE DATE OF THE INCIDENT AND THE DOCTOR STATED IT'S LIKELY FROM A BURN. THE PATIENT STATED THE WOUND WAS PAINFUL BUT NOT ITCHY AND DENIED ANY OTHER CONCERN DURING THE TREATMENT. THREE PROVIDED UNDATED PICTURES WERE REVIEWED BY THE SOLTA MEDICAL REVIEWER. IN THE FIRST PHOTO, NO INJURY IS VISIBLE. IN THE

    Patient problems: Blister; Burn(s); Erythema; Scar Tissue

    MAUDE report 20540657 ↗
  • InjuryMay 10, 2024Excessive Heating; Excessive Heating

    THE PATIENT WAS INSTRUCTED TO USE DRESSING AND HYPERBARIC OXYGEN THERAPY. HEAT OR ICE AND OVER-THE-COUNTER TREATMENTS WERE APPLIED AT HOME BY THE PATIENT.

    Patient problems: Blister; Erythema; Partial thickness (Second Degree) Burn; Skin Inflammation/ Irritation; Superficial (First Degree) Burn; Swelling/ Edema

    MAUDE report 19290569 ↗

Other Massager, Therapeutic, Electric devices

All Massager, Therapeutic, Electric devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page